CREB1 and neoplasm: While it is reported that the hyperactivation of the cAMP/CREB pathway [75], as well as a greater mitochondrial activity [19], results in a loss of chemotherapy resistance in OC, the inhibition of CREB phosphorylation has been shown to sensitize tumor cells to platinum-based therapy, thereby limiting cancer recurrence [27,76].